News

Morgan Stanley MS is set to announce second-quarter 2025 earnings on July 16 before the opening bell. The company’s performance and the subsequent management conference call are expected to grab ...
Morgan Stanley (MS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...
Morgan Stanley's Series E preferred shares offer a 7.1% yield, strong coverage, and resilience. Check out my analysis of MS ...
Passive investing, “short-termism,” and lottery-style behavior have led to valuation distortions in small caps, which may now ...
Morgan Stanley MS shares have gained 11.2% in the past 3 months, outperforming the S&P 500 Index’s 5.2% rise and its industry’s 10% growth. Moreover, the stock has performed better than its ...
Is MS poised to benefit from the global M&A rebound despite rising costs and a premium valuation? Let's have a closer look.
KKR shares have fallen 9% year-to-date, underperforming the alternative asset manager group, which is down 2%, and the S&P ...
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is one of the 11 best debt-free stocks to invest in right now. On July 2, Morgan ...
M&M Financial Services shares rose on July 3 after the company posted a steady Q1 business update. However, Morgan Stanley ...
Today, Zacks Equity Research discusses Morgan Stanley MS, The Goldman Sachs Group, Inc. GS and Robinhood Markets, Inc. HOOD ...
“According to CNBC, under the latest ‘big beautiful bill’ passed by the U.S. Senate on July 1, tax credits for those ...
Buying $1000 In MS: If an investor had bought $1000 of MS stock 5 years ago, it would be worth $2,906.60 today based on a price of $141.90 for MS at the time of writing.